ndd’s portable spirometer shown to deliver accurate, consistent results in the most challenging of environments
Download
Freediver, Vertical Blue Competitor and British National Record Holder Gary McGrath using the EasyOne Air. (Photo: Business Wire)
Freediver, Vertical Blue Competitor and British National Record Holder Gary McGrath using the EasyOne Air. (Photo: Business Wire)
November 08, 2022 08:47 AM Eastern Standard Time
ANDOVER, Mass.--( BUSINESS WIRE )-- ndd Medical Technologies (ndd) , a global leader and innovator of diagnostic devices for the early detection of COPD and other chronic lung diseases, announces the successful deployment of its EasyOne Air portable spirometer for testing lung function at the world’s largest freediving competition, Vertical Blue. In a true test of the EasyOne Air’s capabilities in challenging field conditions, the benefits of the portable spirometer shone through, yielding accurate and consistent results in a sample of freedivers. Freediving is a form of underwater diving where participants plunge to depths as great as 100m, whilst holding their breath for periods of 3-4 minutes. The extreme nature of the sport puts freedivers at risk of lung barotrauma, pulmonary edema, and decompression sickness. The medical team at Vertical Blue wanted to ensure the safety of freedivers at the competition, and set about testing the participants’ lung function to find trends and establish ‘normal’ values in this extreme diving population. As part of a long-term initiative, the medical team also aimed to demonstrate that the activity can be safe, and to identify any associated risks. Thanks to the EasyOne Air’s unique ultrasonic flow measurement technology, highly accurate and consistent spirometry measurements were readily taken in the field, eliminating the need for cumbersome equipment associated with traditional spirometry methods. With instant results and no calibration or maintenance necessary, the team at Vertical blue were delighted with the device’s performance as Jamie Juliano RN, CFRN and co-owner of Freedive Medicine LLC, commented:
“Freediving presents unique challenges for our medical team: Freediving often operates in austere locations where medical equipment is sparce. The EasyOne Air helped us to research and evaluate pulmonary-related risks and proved to be an invaluable tool during the competition. Having ndd by our side will aid in continued evaluation of the unique pulmonary situations Freedivers face when participating in this sport.”
EasyOne Air is designed to deliver accurate results immediately. With unique technology, premium precision components, and extensive quality control standards, high-quality spirometry results are always guaranteed. For further information visit: https://nddmed.com/products/spirometers/easyone-air . ndd is committed to furthering all areas of lung function research. Find out more about the projects supported by ndd at: https://nddmed.com/ndd/company/clinical-research .

ndd’s EasyOne Air Tested to New Depths in World’s Largest Freediving Competition

Global Pulmonary Function Testing Systems Market With Growing CAGR Over The Forecast Period 2021-2027
Pune, Maharashtra, India, March 30 2021 (Wiredrelease) MarketDesk –:The Pulmonary Function Testing Systems market research report for 2021 targets to justify the requirement of the customers searching for various viewpoints towards the global Pulmonary Function Testing Systems market. The report delivers a specialized and in-depth analysis of the existing market situation of the global Pulmonary Function Testing Systems market including the competitive outlook, market synopsis, and revenue prediction over the forecast period 2027. The global Pulmonary Function Testing Systems market report is anticipated at a significant rise by end of 2027, with growing CAGR over the forecast period 2021-2027. Moreover, this Pulmonary Function Testing Systems report provides significant information for the upcoming companies and enterprises by presenting industrial production structure, Pulmonary Function Testing Systems business approaches and applications towards new projects for investment purpose. Sample Report | To comprehend the whole Pulmonary Function Testing Systems report @  https://marketdesk.org/report/global-pulmonary-function-testing-systems-market-hny/105852/#requestForSample
Major market players involved in the global Pulmonary Function Testing Systems market report are: CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD, MGC Diagnostics, Minato, Ganshorn, AESRI, Morgan Scientific, M&B, Sikeda, RSDQ
Global Pulmonary Function Testing Systems market, type wise segmentation: 
Portable PFT Systems
Geological region segmentation of the Worldwide Pulmonary Function Testing Systems market includes:
North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, and South America
Significant points roofed under the Pulmonary Function Testing Systems market research are:
— The Pulmonary Function Testing Systems market volume and growth rate over the forecast period 2027. — Major factors driving growth of the Pulmonary Function Testing Systems market. — Basic market trends influencing the growth of the Pulmonary Function Testing Systems market. — Major challenges involved in the expansion of the Pulmonary Function Testing Systems market. — Market players included in the global Pulmonary Function Testing Systems market. — Major threats and market opportunities confronted by the sellers in the Pulmonary Function Testing Systems market. — Explains the significant results benefited through the five forces analysis included in the Pulmonary Function Testing Systems market. Further, clients will appreciate the Pulmonary Function Testing Systems report comprising of comprehensive information related to all the aspects considered in the market. It includes valuable stats, and most important Pulmonary Function Testing Systems expert’s involvement in gathering the information, to make the report more presentable. There are 15 chapters covered in the global Pulmonary Function Testing Systems market report:
Chapter 1, Explains the definition, clarification, and categorization of the global Pulmonary Function Testing Systems market, application, and market split by regions. Chapter 2, Examines the production cost layout, Pulmonary Function Testing Systems raw material, and distributors, production process, company analysis structure. Chapter 3, It includes technical information, export and import analysis, research, and Pulmonary Function Testing Systems development updates. Chapter 4, preview the overall Pulmonary Function Testing Systems market study, volume analysis based on company segment, trader’s analysis, pricing analysis. Chapter 5 and 6, illustrates the Pulmonary Function Testing Systems market breakdown on a regional basis that includes the of the Pulmonary Function Testing Systems market by type. Chapter 7 and 8, scrutinizes the Pulmonary Function Testing Systems market study by application and key market player’s analysis. Chapter 9, Various Pulmonary Function Testing Systems market trends study, regional trends, the market tendency by type, and by applications. Chapter 10 and 11, It involves client analysis of the global Pulmonary Function Testing Systems market by type, application, and region, as well regional and international market analysis. Chapter 12, explains Pulmonary Function Testing Systems market research findings, methodology, data source, conclusion and appendix. Chapter 13, 14 and 15, defines Pulmonary Function Testing Systems market through the various distribution channel, dealers, traders, supply, and demand, imports, and exports. The global Pulmonary Function Testing Systems market highlights the key factors driving the growth of this market, along with restraining factors, opportunities, major challenges, and upcoming Pulmonary Function Testing Systems market trends. It also serves a brief analysis of the market situation, segmentation, revenue projection, and geological regions of the Pulmonary Function Testing Systems market. In addition, it offers market position from the reader’s point of view, sharing certain facts related to Pulmonary Function Testing Systems market and business views. Trending Research Report:

Global Pulmonary Function Testing Systems Market With Growing CAGR Over The Forecast Period 2021-2027

Thomas Sinclair named Vice President of Sales and Marketing of ndd      Medical Technologies; Patti Peters named Senior Director Strategic      Accounts. April 12, 2018 02:56 PM Eastern Daylight Time
ANDOVER, Mass.--( BUSINESS WIRE )--ndd Medical Technologies, Inc., the leader in lung function testing,      announced that Patti Peters, the long-term Vice President of Sales and      Marketing, handed over the reins to Thomas Sinclair. Tom has held      several positions at Medtronic, most recently as Director of Sales,      Alternate Site in Boulder, CO. Patti will continue her full-time role at      ndd and assumes the title of Senior Director Strategic Accounts. “Patti joined ndd in 1999 and pioneered the establishment of the EasyOne      brand and instituted ndd products as market leader in spirometry in the      U.S. among opinion leaders in clinical research, the medical community      and with our distribution partners,” noted ndd Medical Technologies,      Inc. “Her deep      understanding of the ndd brand and more importantly, the ever-evolving      needs of our customers will be crucial assets to support the continuous      growth of ndd’s innovative products for early diagnosis of lung disease.”
Patti Peters: “The past 19 years have been a rewarding experience      for me and I’m thrilled we have identified Tom Sinclair as my successor. I feel extremely confident in his ability to lead the continuous      expansion of the ndd brand in the US and Canadian medical community.”
Tom Sinclair joins ndd after more than 13 years with Medtronic. Tom’s      leadership experience in both Acute and Alternate Site markets has him      uniquely positioned to help ndd execute on our core mission of driving      early detection for people living with COPD and other chronic lung      diseases. “It is an exciting opportunity to join an organization with      tremendous potential and superior technology and grow the business in a      meaningful way to create better patient outcome and reduce cost for the      medical community,” says Tom. In his nearly 20 years of sales and      marketing experience, he has a proven track record of success in driving      market growth in mature product lines and successful new product      launches, which makes his hiring a perfect fit with ndd’s expanding      market presence. About ndd Medical Technologies
For more than 20 years ndd      has worked to improve the early detection and accurate diagnosis for      people living with COPD and other chronic lung diseases with EasyOne      products. In that time, ndd has grown to be the leading global innovator      in PFT devices by supporting research, helping to create awareness,      launching innovative products and making them available in over 100      countries. The EasyOne product line was developed for physicians to offer accurate      and reliable diagnosis at the point of care and start immediate      treatment. This helps avoid irreversible lung damage for millions of      patients while significantly reducing healthcare cost. Learn more by      visiting our website at https://www.nddmed.com .

Thomas Sinclair named Vice President of Sales and Marketing of ndd Medical Technologies; Patti Peters named Senior Director Strategic Accounts.

February 20, 2018 02:13 PM Eastern Standard Time
ANDOVER, Mass.--( BUSINESS WIRE )--Pulmonary function testing is a vital component to determining the onset      of lung disease. ndd      Medical Technologies’ new spirometer, the EasyOne Air has been      approved by NIOSH for use in the Coal Worker’s Health Surveillance      Program (CWHSP) for the completion of periodic lung function testing for      underground and surface coal miners. The EasyOne® Air is the third ndd      product approved for use in the CWHSP. The EasyOne      Air is a flexible, accurate and proven spirometry solution. Utilizing TrueFlow™ technology, this portable and PC spirometer delivers      reliable results every time. With a vivid color touch screen for fast      entry of patient data, easy navigation and real time results this      product is an exceptional choice to use onsite or in clinical      environments. In a recent research letter published      in the Journal of the American Medical Association , NIOSH confirmed      416 cases of progressive massive fibrosis or complicated black lung from      2013 to 2017, which indicates a significant growth of cases. NIOSH      regulations require periodic spirometry screenings for both underground      and surface coal miners. The pulmonary function testing must be done in      NIOSH-approved facilities and administered by testers who have      successfully completed the organization’s Spirometry Training Course. The Coal Worker’s Health Surveillance Program focuses on employees      exposed to coal and silica dust that could cause black lung disease,      silicosis or Chronic Obstructive Pulmonary Disease (COPD). NIOSH      Spirometry Course Director Rebecca Moreland, Ph.D., MPH, uses the      EasyOne Air and Easy on-PC for training occupational health nurses and      professionals performing spirometry in the field and workplace. “The EasyOne PFT devices are very portable and are easy to take in to      the field or plant,” stated Dr. Moreland. “The EasyOne ultrasound      technology is not only accurate but provides on-the-spot predictive      values and easy identification of repeatable lung function results. Its      concise printouts and graphic displays highlight lung function      parameters and results, including preliminary interpretation. And the      ndd technology saves the information directly from the spirogram into a      database or Electronic Health Record (EHR).”
About ndd Medical Technologies, Inc.
With over 40 percent of the U.S. spirometry market share, ndd Medical      Technologies offers innovative, easy-to-use pulmonary function testing      instruments that help clinicians diagnose lung disease with greater      precision for optimal treatment. The EasyOne® line of spirometry and PFT      devices are the most consistent and user-friendly lung function testing      equipment on the market. ndd’s patented Ultrasonic TrueFlow™ technology,      eliminates problems associated with traditional methods of flow      measurement, making testing fast, reliable and error free. To learn      more, visit www.nddmed.com .

ndd Medical’s EasyOne® Air Approved for Coal Worker’s Surveillance Program

aTyr Pharma Announces Presentations on Interstitial Lung Disease and the iMod.Fc Program at the American Thoracic Society 2017 International Conference and Will Host an Educational Webinar
ndd      Medical Technologies, Inc. , the leader in lung function testing,      today announced the company will showcase the latest versions of its      best-in-class spirometer and portable, all-in-one DLCO devices at the      annual American      Thoracic Society (ATS) Conference May 19-24 in Washington, D.C.
“Our diagnostic solutions ensure providers can accurately diagnose      patients early, right at the point of care vastly improving the quality      of life for patients living with lung disease,” said Georg Harnoncourt,      CEO of ndd Medical Technologies. “Because all of our devices are powered      by one software solution [the EasyOne Connect platform] we can offer      seamless integration with electronic medical records.”
Exhibiting at booth #1521, ndd will demonstrate a variety of diagnostic      solutions powered by the secure EasyOne Connect platform, including      EasyOne Air, a PC-based and portable spirometer and EasyOne Pro , a portable, diffusion      capacity (DLCO) assessment , spirometer and full lung volume      measurement. These lung function tests employ ndd’s proprietary Ultrasonic      TrueFlow Measurement eliminating errors associated with traditional      methods of flow measurement (heat, humidity, etc.) With no moving parts,      no codes to enter, no screens to catch sputum and no disposables to      calibrate, these diagnostic devices ensure extraordinarily fast,      reliable and error free results. “My clinical research on asthma and COPD happens at the point of care in      some of the most remote, resource limited places in the world,” said William      Checkley , MD, associate professor at John Hopkins Bloomberg School      of Public Health. “Because of this, I need highly portable, very durable      diagnostic devices reporting consistent and accurate results even under      the toughest conditions. I use ndd’s devices because I know no matter      the condition, the device will report accurate results.”
Visit the ndd Medical Technologies booth #1521 at ATS 2017 in the Walter      E. Washington Convention Center in Washington, D.C. For more information      on ndd Medical Technologies’ solutions and updates, please visit www.nddmed.com or follow @nddMedical . About ndd Medical Technologies:
A leader in lung function      testing based in Switzerland and the U.S., ndd is helping to improve the      quality of life for millions of people living with lung disease. Built      around the company’s patented Ultrasonic TrueFlow™ technology, ndd's      innovative, easy-to-use products such as EasyOne® and EasyOne Pro® help      clinicians diagnose and treat COPD and other chronic lung diseases      earlier and with greater precision by providing accurate information at      the point of care. For more information on ndd, please visit  www.nddmed.com  or      follow us on Twitter  @nddMedical . View source version on businesswire.com: http://www.businesswire.com/news/home/20170515005973/en/
ndd Medical Technologies

ndd Medical Technologies Debuts New Diagnostic Devices at the 2017 American Thoracic Society ATS Conference

Vizient operates in the health sector. The company provides spend management, data and digital solutions, consulting, and member networks. Vizient primarily serves acute care providers, including academic medical centers and ambulatory care providers. Vizient was formerly known as VHA. It was founded in 1977 and is based in Irving, Texas.

Vizient

-LSB- Andover , MA , April 13 , 2023 -RSB- -- ndd Medical Technologies announced its TrueFlow ultrasound technology has received an Innovative Technology contract from Vizient , Inc. the nation 's leading health care performance improvement company .

ndd Medical Technologies Receives Innovative Technology Contract from Vizient for TrueFlow Technology Used in EasyOne Product Line

Zinsser Analytic

Resmed

Signify

Philips

Private Equity

NDD Medizintechnik specializes in pulmonary function testing devices. The company offers portable and PC spirometers, complete pulmonary function testing machines, and integrated software platforms. NDD Medizintechnik primarily serves healthcare systems, primary care, allergy & asthma specialists, and pulmonology sectors. It was founded in 1992 and is based in Zurich, Switzerland.

Date	9/22/2015
Round	Private Equity
Amount
Investors	BWK, and SHS Capital
Valuation	$XXM
Revenue	0 FY undefined
Sources	1

First funding	Last Funding	Investor	Rounds	Board Seats	Type	Location
9/22/2015	9/22/2015	SHS Capital	1 Private Equity		Venture Capital	Germany
00/00/0000	00/00/0000	BWK	Subscribe to see more		Private Equity	Germany

First funding	9/22/2015	00/00/0000
Last Funding	9/22/2015	00/00/0000
Investor	SHS Capital	BWK
Rounds	1 Private Equity	Subscribe to see more
Board Seats
Type	Venture Capital	Private Equity
Location	Germany	Germany

How VCs Use CB Insights

Professional Services

Platform Overview

NDD Medizintechnik

Investors Count

Funding, Valuation & Revenue

NDD Medizintechnik Investors